ISRIB
ISRIB (Integrated Stress Response Inhibitor) is a small molecule that has been identified as a potent inhibitor of the integrated stress response (ISR). The ISR is a cellular response to various forms of stress, including endoplasmic reticulum stress, oxidative stress, and amino acid deprivation. ISRIB has shown promise in preclinical studies for its potential therapeutic applications in various neurological and cognitive disorders.
Mechanism of Action[edit]
ISRIB functions by inhibiting the phosphorylation of the eukaryotic initiation factor 2 alpha (eIF2α), a key step in the ISR pathway. Under stress conditions, eIF2α is phosphorylated by kinases such as PERK, PKR, GCN2, and HRI, leading to a reduction in global protein synthesis and the activation of stress response genes. ISRIB prevents this phosphorylation, thereby restoring normal protein synthesis and cellular function.
Therapeutic Potential[edit]
ISRIB has been studied for its potential to treat a variety of conditions, including:
- Traumatic brain injury (TBI)
- Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease
- Cognitive impairments associated with aging
- Down syndrome
In animal models, ISRIB has been shown to improve cognitive function and memory, suggesting its potential as a therapeutic agent for cognitive disorders.
Research and Development[edit]
Research on ISRIB is ongoing, with studies focusing on its efficacy, safety, and potential applications in human medicine. Preclinical studies have demonstrated its ability to cross the blood-brain barrier and exert its effects in the central nervous system.
See Also[edit]
- Integrated stress response
- Endoplasmic reticulum stress
- Eukaryotic initiation factor 2
- Neurodegenerative diseases
- Cognitive disorders
References[edit]
External Links[edit]
-
 | This medical article is a stub. You can help WikiMD by expanding the page. |
